共 394 条
- [1] Delgado-Lopez PD(2016)Survival in glioblastoma: a review on the impact of treatment modalities Clin Transl Oncol 18 1062-1071
- [2] Corrales-Garcia EM(2020)A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14 – 01) Neuro Oncol 22 1851-1861
- [3] Balana C(2014)High-grade glioma: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up Ann Oncol 25 iii93-101
- [4] Vaz MA(2021)Progress and prospect in Tumor treating fields treatment of glioblastoma Biomed Pharmacother 141 111810-186
- [5] Manuel Sepulveda J(2021)EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood Nat Rev Clin Oncol 18 170-2543
- [6] Mesia C(2015)Maintenance Therapy with Tumor-Treating Fields Plus Temozolomide vs Temozolomide alone for Glioblastoma: a Randomized Clinical Trial JAMA 314 2535-503
- [7] Del Barco S(2014)Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline Curr Oncol 21 e493-504
- [8] Pineda E(2017)Clinical relevance of Steroid Use in Neuro-Oncology Curr Neurol Neurosci Rep 17 5-1471
- [9] Munoz-Langa J(2015)Medical management of brain tumors and the sequelae of treatment Neuro Oncol 17 488-241
- [10] Estival A(2016)Corticosteroids compromise survival in glioblastoma Brain 139 1458-188